Munch, M., Granholm, A., Myatra, S., Vijayaraghavan, B., Cronhjort, M., Wahlin, R., Jakob, S. M., Cioccari, L., Kjær, M., Vesterlund, G., Meyhoff, T., Helleberg, M., Møller, M., Benfield, T., Venkatesh, B., Hammond, N., Micallef, S., Bassi, A., John, O., Jha, V., Kristiansen, K., Ulrik, C., Jørgensen, V., Smitt, M., Bestle, M. H., Andreasen, A., Poulsen, L., Rasmussen, B., Brøchner, A., Strøm, T., Møller, A., Khan, M., Padmanaban, A., Divatia, J., Saseedharan, S., Borawake, K., Kapadia, F., Dixit, S., Chawla, R., Shukla, U., Amin, P., Chew, M. S., Gluud, C., Lange, T., & Perner, A. (2021). higher vs lower doses of dexamethasone in patients with COVID‐19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan. Acta anaesthesiologica scandinavica, 65(6), 834–845. http://access.bl.uk/ark:/81055/vdc_100132237662.0x000063